90/016,705DETERMINING BIOLOGICAL PROPERTIES OF ATHEROSCLEROTIC PLAQUE, CORONARY ARTERY DISEASE, OR VASCULOPATHY12,159,406Open
Status
Reexam Preprocessing Completed - Released to Assigned GAU
Filed
Oct 26, 2026
Pre-Order Paper
Window open until about Dec 5, 2026
Last Updated
Nov 2, 2026
Examiner
Not assigned
Art Unit
Requester
Requester Law Firm
Requested By
Third Party
Patent Owner(via USPTO assignment records)
Patent Owner Law Firm
Owner hasn't filed yet
Reexam History (15 events)
Nov 2, 2026FTFSFITF set to YES - revise initial setting
Nov 2, 2026RXNREQAUNotice of assignment of reexamination request
Nov 2, 2026RXTTLRPTTitle Report
Nov 2, 2026RXPCOMCompletion of Preprocessing - Released to Assigned GAU
Nov 2, 2026RXNREQFDNotice of reexamination request filing date
Oct 28, 2026PRXRParalegal Reexam Review Complete
Oct 28, 2026RXLITSRReexam Litigation Search Conducted
Oct 26, 2026WIDSInformation Disclosure Statement (IDS) Filed
Oct 26, 2026RXOSUB.RReexamination requested by third party requester
Oct 26, 2026BIG.Entity Status Set To Undiscounted (Initial Default Setting or Status Change)
Oct 26, 2026RXOSUBReceipt of Original Ex Parte Reexam Request
Oct 26, 2026RXAF/DAffidavit(s), Declaration(s) and/or Exhibit(s) Filed
Oct 26, 2026RXIDS.RReexam - Information Disclosure Statement Filed by Third Party Requester
Oct 26, 2026WIDSInformation Disclosure Statement (IDS) Filed
Oct 26, 2026WIDSInformation Disclosure Statement (IDS) Filed
Prosecution, PTAB & CAFC
PTAB Proceedings (IPR, PGR, CBM, DER)
None found
Federal Circuit (CAFC)
None found
Terminal Disclaimer
None found
Prosecution History
None found
Maintenance Fees
Grant
Dec 3, 2024
3.5-yr
Jun 3, 2028
7.5-yr
Jun 3, 2032
11.5-yr
Jun 3, 2036
Expiry
Dec 19, 2043
Entity Status
Small Entity
Expires
Dec 19, 2043 (17.1 yr remaining)
Assignments
AssignmentReel/Frame: 065922/0496Recorded: Dec 20, 2023
From
ANDREW J. BUCKLERInventor
Jan 4, 2016
KJELL JOHNSONInventor
Jan 7, 2016
XIAONAN MAInventor
Jan 6, 2016
KEITH A. MOULTONInventor
Jan 7, 2016
DAVID S. PAIKInventor
Jan 4, 2016
→
To
ELUCID BIOIMAGING INC.